Abstract Background/Aims: Acute lung injury/acute respiratory distress syndrome (ALI/ARDS) is a serious health problem, and an effective treatment is needed for use in the clinical setting. Methods: In this study, we first constructed ALI models in Adult Sprague-Dawley rats. We then used an herbal medicine, Houttuynia cordata (HC), to enhance the effect of endothelial progenitor cells (EPCs) on ALI. Results: (1) HC improved the therapeutic effects of EPCs on lipopolysachharide-induced ALI in the rat model; (2) HC down-regulated the anti-inflammatory response by suppressing inflammatory cytokines; (3) the combination of EPC and HC reduced expression of iNOS and ET-1 and subsequently prevented lung injury. Conclusion: Combined EPC and HC therapy was more effective than either therapy alone. EPC and HC could be used in the clinical treatment of ALI.
Introduction
Cell transplantation is a novel strategy that has been used in the treatment of incurable human diseases [1] [2] [3] . Endothelial progenitor cells (EPCs), a heterogeneous subpopulation of bone marrow mononuclear cells, are thought to contribute to vascular homeostasis and endothelial repair [4] . EPCs were first isolated from the mononuclear cell fraction of human peripheral blood [5] . In adults, EPCs may move to sites of injury or a site of neovascularization and then differentiate into mature endothelial cells, thus contributing to re-endothelialization and neo-vascularization [6, 7] . An increased number of EPCs is often observed in patients
Characterization of EPCs
EPCs were characterized by intake of 1,1-dioctadecyl-3,3,3,3-tetramethylindocarbocyanine-labeled acetylated low-density lipoprotein (Dil-ac-LDL) and fluorescein isothiocyanate-labeled Ulex europaeus agglutinin-1(FITC-UEA-1). Cells were sequentially incubated with Dil-ac-LDL (10 μg/ml, Molecular Probes, Eugene, OR, USA) and FITC-UEA-1(10 μg/ml, Sigma). Cells were examined using inverted fluorescence microscopy (Olympus, Tokyo, Japan), and double-positive cells were identified as EPCs.
Flow cytometer (FCM) detection of surface markers on EPCs
Adherent cells were digested into a single-cell suspension, blocked for 30 min, and incubated with FITC-conjugated CD34 (BD Biosciences, Baltimore, MD, USA), PE-conjugated VEGFR2 (R&D Systems Inc., Minneapolis, MN, USA), FITC-conjugated CD146 (BD Biosciences), FITC-conjugated vWF (R&D), CD133 (Abcam, Cambridge, MA, USA), or PE-conjugated anti-human kinase insert domain-conjugating receptor (KDR; R&D) for 30 min at 4 °C. They then were washed twice with PBS. Suspensions were immediately analyzed by a FACSCalibur machine (BD Biosciences).
Treatment procedures A 1.5-cm longitudinal incision was made on the ventral surface of the neck of rats, and the right external jugular vein was exposed. Rats were injected with PBS or EPCs (approximately 5 × 10 6 in 200 μl PBS). After surgery, rats were sutured and sterilized according to normal procedure and allowed to recover spontaneously from the anesthesia. Rats with or without EPC transplantation were injected with HC (50 mg/g) via the tail vein every day.
Blood gas analysis
Seven days after treatment, arterial blood was drawn from the ear artery of rats with ALI under roomair conditions. Oxygen saturation (Sa O2 ) and Po2 (Pa O2 ) in the arterial blood were analyzed using a blood gas analyzer (ABL 520, Radiometer, Copenhagen, Denmark).
Plasma cytokine measurements
Plasma samples were obtained from rats 7 days after treatment. TNF-α and IL-10 levels were measured in plasma samples using ELISA kits (R&D).
Determination of bronchoalveolar lavage (BAL) protein
BAL was performed by intratracheal injection of 10 mL PBS followed by gentle aspiration. Recovered fluid was pooled and centrifuged at 500 g for 10 min at 4 °C. Supernatants were removed and stored at -20 °C until testing was performed. Total protein was quantified in BAL using the bicinchoninic acid method as provided by the manufacturer (Pierce, Rockford, IL, USA).
Lung wet-to-dry ratio
Seven days after treatment, the intermediate lobe of the right lung was excised and weighed immediately. Lung tissues were dried in an oven at -80 °C for 12 h and reweighed. The lung wet-to-dry ratio was obtained by dividing the mass of the initial specimen by the mass of the dried specimen.
RNA isolation and reverse transcriptase-polymerase chain reaction (RT-PCR) of the sry gene
Total RNA was isolated form the intermediate lobe of the right lung using an RNeasy Mini Kit (Biomed, Beijing, China). First strand cDNA was reverse transcribed with 1 μg of total RNA using the TaKaRa Reverse Transcription Kit (TaKaRa, Dalian, China) and oligo (dT) 15 primers (TaKaRa). The sry primers were 5'-GCCTCATCGAAGGGTTAAAGTG-3' (forward primer) and 5'-GAGGACTGGTGTGCAGCTCTA-3' (reverse primer). The housekeeping gene GAPDH was used as an internal control for normalization of the results. The GAPDH primers were 5'-AGAAGGCTGGGGCTCATTTG-3' (forward primer) and 5'-AGGGGCCATCCACAGTCTTC-3' (reverse primer). PCR amplification of cDNA was performed in 20 μl mixtures. Finally, amplicons were electrophoresed in 2% agarose gel with ethidium bromide and visualized under UV illumination.
Gelatin zymography
Fifty micrograms of protein were applied to 10% polyacrylamide gels with 1% gelatin incorporated as a substrate for gelatinolytic protease analysis. After running the gel the SDS was removed by washing twice in 2.5% Triton X-100 for 30 min. The gels were incubated overnight in zymography development buffer containing 50 mM Tris-HCl (pH = 7.4), 2 mM NaN 3 , and 5 mM CaCl 2 . After development the gels were stained for 3 h in 45% methanol/10% glacial acetic acid containing 1% (w/v) Coomassie Blue R-250; the gels subsequently were partially destained with the same solution without dye. The gelatinolytic activity of each matrix metalloproteinase (MMP) was qualitatively evaluated as a clear band against the blue stained gelatin background.
Western blotting analysis
Tissues from the intermediate lobe of the right lung were lysed in lysis buffer (20 mM Tris-HCl, 150 mM NaCl, 2 mM EDTA, 1% Triton-X100) containing a protease inhibitor cocktail (Sigma). Equivalent amounts of protein (60 μg) were separated using 10% SDS-PAGE and transferred to a PVDF membrane (Millipore Corporation, Billerica, MA, USA). Western blotting was performed using the following primary antibodies (Santa Cruz Biotechnology, Santa Cruz, CA, USA): iNOS (sc-8310), ET-1 (sc-21625), MMP-2 (sc-8835), MMP-9 (sc-12759), TIMP-1 (sc-5538), TIMP-2 (sc-365671), and β-actin (sc-130657,). The binding of each specific antibody was detected with horseradish peroxidase-conjugated respective secondary antibodies (Amersham Biosciences, Amersham, UK) and ECL solutions (Amersham Biosciences). The intensity of each Western blot band was semi-quantified using Quantity One software (Bio-Rad, Hercules, CA, USA).
Statistical analysis
Statistical analyses were performed using GraphPad PRISM 4 software (San Diego, CA, USA). Overall survival of rats was analyzed using the Kaplan-Meier method, and the significance of differences in survival rates was estimated using the log rank test. Values of P < 0.05 were considered to be significant.
Results

Characterization of EPCs
EPCs isolated from rat bone marrow displayed characteristic EPC phenotypes, as indicated by their uptake of Dil-acetyl-LDL and expression of UEA-I (Fig. 1A) . The EPCs also displayed expression of CD34, vWF, CD146, VEGFR2, CD133, and KDR on the plasma membrane (Fig. 1B) .
Engraftment of EPCs to the injured lung
Following the methods of Mao et al. [18] , the engraftment of male donor cells in female recipients was assessed by RT-PCR of the Y chromosome-specific gene sry. As shown in Figure  1C , sry gene expression was detected using RT-PCR in the recipient female lung tissues after treatment. Figure 2A shows histological sections of rat lung tissues. There were no obvious lesions on the lung tissues of untreated and EPC-treated rats. In the PBS-treated group, the size of the pulmonary alveolus cavity decreased and thickening of the alveolar wall was observed. The EPC-treated group showed reduced damage, including decreased formation of a hyaline membrane, reduced thickness of the alveolar wall, and lower number of inflammatory cells in the lung interstitium. Compared with the other groups, the combined application of EPC and HC had the best effect ( Fig. 2A) .
Combined application of EPC and HC treatment attenuated the severity of lung injury and improved the survival rate of rats
Pulmonary edema is a hallmark of ALI, and it consists of various degrees of water and proteins [19] . Disruption of the alveolar-capillary barrier was assessed by measuring the water content in the lung. The lung wet-to-dry ratio was reduced in the EPC-treated rats (31.5 ± 4.24% vs. 45.3 ± 4.35% in the LPS group; Fig 2B, P < 0.05). EPC and HC-treated rats (24.9 ± 2.96%) showed a lower lung wet-to-dry ratio than the EPC-treated group (31.5 ± 4.24%) or the HC-treated group (32.7 ± 3.52%) (Fig. 2B , P < 0.05).
Bronchoalveolar lavage (BAL) protein is a marker of endothelial and epithelial permeability [20] . Concentration of the BAL protein was significantly reduced in the EPCand HC-treated group (189.6 ± 33.7 ng/ml) compared with the EPC-treated group (356.7 ± 39.6 ng/ml), the HC-treated group (348.6 ± 32.5 ng/ml), and the LPS group (758.3 ± 36.8 ng/ml) ( Fig. 2C , P < 0.05). In comparison with the LPS group, Pa O2 and Sa O2 were significantly improved in rats receiving EPC transplantation (Fig. 2D , P < 0.05). Unfortunately, HC treatment had no effect on Pa O2 and Sa O2. Rats in both the EPC-treated group and the HCtreated group showed a significantly higher survival rate compared with the LPS group ( Fig.  2E, P < 0.01) . Moreover, the survival rate of rats treated with EPC and HC was higher than that of rats treated with either EPC or HC alone (Fig. 2E , P < 0.01).
EPC and HC treatment altered cytokine responses
The level of proinflammatory cytokine TNF-α in the plasma was about 2-fold higher in the LPS group compared with the EPC-treated group (65.3 ± 4.86 pg/ml vs. 33.2 ± 4.25 pg/ml, P < 0.05) (Fig. 3A) . The TNF-α level was significantly reduced in the HC-treated group (14.8 ± 4.89 pg/ml) compared with the EPC-treated group and the LPS group (P < 0.05). Rats in the LPS group had a significantly higher level of IL-10 than those in the untreated group (58.8 ± 3.25 pg/ml vs. 13.6 ± 1.05 pg/ml, P < 0.05) (Fig. 3B) . There was no significant difference of the plasma level of IL-10 between the LPS group and the EPC-treated group (58.8 ± 3.25 pg/ml vs. 56.9 ± 3.65 pg/ml). Interestingly, the HC-treated group (18.6 ± 3.98 pg/ml) had a lower IL-10 concentration compared with the LPS group and EPC-treated group.
Mechanism(s) of action EPC and HC on ALI
The expression levels of ET-1 and iNOS in the LPS group were higher than the levels in rats treated with EPC, HC, or the combination of EPC and HC (Fig. 4B, P < 0.05) . Western The lung interstitium of the treated group showed reduced cavities of pulmonary alveoli, formation of hyaline membranes, and hemorrhage. EPC and HC significantly decreased the lung wet/dry ratio B) and BAL protein concentration C). D) The P O2 (Pa O2 ) and oxygen saturation (Sa O2 ) in arterial blood were significantly improved in rats receiving EPC and HC treatment. E) Kaplan-Meier survival curves of the groups described in the Material and Methods section. Compared with the PBS-treated rats, rats that received EPC and HC treatment had a significantly higher survival rate.
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blotting analysis revealed that the levels of MMP-2, MMP-9, TIMP-1, and TIMP-2 in the LPS group were also significantly higher than those in the untreated group (Fig. 4) . However, rats in the EPC-and HC-treated groups had lower levels of MMP-2, MMP-9, TIMP-1, and TIMP-2 than rats in the LPS group. Consistent with the results of Western blotting analysis, the activities of MMP-2 and MMP-9 in the LPS group also were inhibited by EPC or HC treatment (Fig. 4A) . The activities of MMP-2 and MMP-9 were lowest in the combination of EPC and HC group. , and TIMP-1/2 extracted from the lung tissues was evaluated using Western blotting and was normalized against β-actin. The bar graph shows significant differences between each group (P < 0.05).
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Discussion
The pathology of ALI and ARDS is caused by transmural alveolar wall damage [11, 21] . In previous studies, EPC transplantation has been demonstrated to be a useful therapeutic method with clinical practical value for treating ALI/ARDS [22, 23] . In this study, we confirmed that EPCs could repair lung damage induced by LPS. ALI and ARDS are characterized by diffuse pulmonary infiltration, increased pulmonary capillary permeability, and development of noncardiogenic pulmonary edema [24] . Transplantation of EPCs significantly reduced the lung wet-to-dry ratio in rabbits with endotoxin-induced ALI. We also found that EPC reduced the lung wet-to-dry ratio in our LPS-induced ALI rat models. These results suggested reduced pulmonary water content in the EPC-treated animals.
The main purpose of this study was to identify the role of HC in LPS-induced ALI. H. cordata is known to be an effective herbal medicine for treating allergic inflammation [15] , and we found that HC is effective in the treatment of pulmonary edema. Combined EPC and HC therapy was more effective than treatment with either EPC or HC alone, as evidenced by the expression levels of iNOS and ET-1. Both iNOS and ET-1 have been shown to be important biomarkers of the ALI disease state and have been used to elevate the inflammatory state via a proinflammatory effect [18] . Consistent with previous studies [18, 25] , expressions of iNOS and ET-1 were significantly up-regulated in the lung tissues of rats with ALI, indicating the presence of oxidative and inflammatory stresses in the injured lung. However, the levels of iNOS and ET-1 were significantly lower in rats after treatment with HC and EPC compared to untreated rats.
In regards to the mechanism of action of HC and EPC for the treatment of ALI, our results demonstrated that these treatments (EPC, HC, or EPC + HC) have potent inhibitory effects on the inflammatory response and the MMP axis. Cytokine IL-10 has been suggested to mediate the anti-inflammatory response via its ability to internalize and thus act as a scavenger of free endotoxin [26] . TNF-α, which is a major proinflammatory cytokine, is produced by many different cell types, including endothelial cells during inflammation [18] . In this study, we found that HC could inhibit IL-10 and TNF-α in LPS-induced ALI. Lee et al. [27] described the beneficial therapeutic effects of HC on Th2-mediated or allergic skin disorders. Consistent with their study, we also found that HC could inhibit inflammatory reactions in ALI. The MMP axis is known to play a crucial role in extracellular matrix remodeling and vascular homeostasis [28] . Early studies showed that increased MMP activity and expression enhanced vascular remodeling in ALI [29, 30] . We confirmed that both MMP-2/9 and TIMP-1/2 were inhibited by the combination of HC and EPC.
The main findings of this study are as follows: (1) HC improved the therapeutic effects of EPCs on LPS-induced ALI in the rat model; (2) HC down-regulated the anti-inflammatory response by suppressing inflammatory cytokines; (3) the combination of EPC and HC reduced expression of iNOS and ET-1 and subsequently prevented lung injury.
